|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3328889 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16756950.8 |
| Date of filing the European patent application | 2016-08-01 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
| (46) | Date of publication of the claims translation | 2021-08-10 |
| (86) | Number | PCT/EP2016/068285 |
| Date | 2016-08-01 |
| (87) | Number | WO 2017/021349 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 201562199930 P | 2015-07-31 | US | |
| 201662290896 P | 2016-02-03 | US |
| (72) |
RAUM, Tobias , DE
KUFER, Peter , DE
PENDZIALEK, Jochen , DE
BLUEMEL, Claudia , DE
DAHLHOFF, Christoph , DE
HOFFMANN, Patrick , DE
LUTTERBUESE, Ralf , DE
NAHRWOLD, Elisabeth , DE
|
| (73) |
Amgen Research (Munich) GmbH ,
Staffelseestrasse 2, 81477 München,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bispecifinio antikūno konstruktai, prisirišantys prie DLL3 ir CD3 |
| BISPECIFIC ANTIBODY CONSTRUCTS BINDING DLL3 AND CD3 |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 10 | 231.00 EUR |
| 2026-08-01 |